1.CCB在国际指南中的地位及2009 ESH进展.pptVIP

2009年欧洲高血压会议2009年6月，意大利 米兰 2009年欧洲指南的更新 2009年欧洲指南的更新 2009年欧洲指南的更新 2009年欧洲指南的更新 2009年欧洲指南的更新 2009ESH指南联合治疗的论述 As mentioned in the 2007 ESH/ESC guidelines, several two-drug combinations are suitable for clinical use. However, trial evidence of outcome reduction has been obtained particularly for the combination of a diuretic+ an ACE inhibitor or an ARB or a CCB, and in recent large-scale trials for the ACE inhibitor/CCB combination. The ARB/CCB combination also appears to be rational and effective. These combinations can thus be recommended for priority use. 2009ESH指南联合治疗的论述 2009年欧洲指南更新-CCB与心力衰